MedTrace Logo

Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases

NCT02780531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-12-26

No results posted yet for this study

Summary

The purpose of this study is to identify genetic or other factors in the subjects blood that may predispose them to getting a particular disease or tell researchers how the disease will behave, for example how fast it will progress or what areas of the body might be affected. A second goal is to relate such factors to how such a condition affects the subjects clinically as well as how it affects the electrical functions of nerves and muscles.

Conditions

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Principal Investigators

  • Sean Goretzke, MD · St. Louis University

Eligibility

Min Age
1 Year
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-10-16
Completion
2018-10-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02780531 on ClinicalTrials.gov